Skip to main content
Adocia logo

Adocia — Investor Relations & Filings

Ticker · ADOC ISIN · FR0011184241 LEI · 969500ZL79KYH9PTYP78 PA Real estate activities
Open in API
Filings indexed 826 across all filing types
Latest filing 2018-02-12 Capital/Financing Update
Country FR France
Listing PA ADOC

About Adocia

https://www.adocia.com

Adocia is a clinical-stage biotechnology company that specializes in developing innovative treatments for metabolic diseases, with a primary focus on diabetes and obesity. The company's core expertise is the development of novel formulations of approved peptides, proteins, and metabolic hormones, such as insulin, to improve their therapeutic efficacy. Adocia leverages proprietary technology platforms to create a pipeline of specialty products. Its research also extends to novel cell therapy approaches, including an immunoprotective scaffold for cell delivery. The company's business model involves advancing its product candidates to clinical proof-of-concept before licensing them to partners for late-stage development and commercialization.

Recent filings

Filing Released Lang Actions
Share buybacks / Liquidity contracts Information related to liquidity contracts
Capital/Financing Update Classification · 1% confidence The document is explicitly titled "PRESS RELEASE" and announces that the company has "allocated an additional EUR 250,000 cash amount to the liquidity agreement." It provides details about the current resources under this agreement and includes standard boilerplate information about the company, its pipeline, and contact details. This type of announcement, which is a brief, time-sensitive update regarding financial arrangements (specifically a liquidity/share buyback agreement), fits best under Capital/Financing Update (CAP) or potentially a general Regulatory Filing (RNS). Since it details a specific action related to capital management (funding a liquidity agreement), CAP is more precise than RNS. It is not a full financial report (10-K, IR), an earnings release (ER), or a dividend notice (DIV). Given the focus on allocating cash to a liquidity agreement, CAP is the most appropriate classification.
2018-02-12 English
Rachat d'actions / Contrat de liquidité Information relative au contrat de liquidité
Regulatory Filings Classification · 1% confidence The document is titled "COMMUNIQUE DE PRESSE" (Press Release) and announces a specific corporate action: an additional cash contribution (€250,000) to the company's liquidity contract managed by Kepler Capital Markets SA. This action relates to the company's share management and financing structure, specifically concerning market liquidity maintenance. This type of announcement, detailing capital structure management or financing activities, aligns best with the 'Capital/Financing Update' (CAP) category. While it involves shares, it is not a general share issue (SHA) or a buyback report (POS), but rather an update on the liquidity agreement funding. It is too specific for a general Regulatory Filing (RNS) and does not fit ER, IR, or CT definitions. Given the focus on funding the liquidity contract, CAP is the most appropriate classification.
2018-02-12 French
Information relative au nombre total de droits de vote et d'actions composant le capital
Share Issue/Capital Change Classification · 1% confidence The document is a press release ("COMMUNIQUE DE PRESSE") published on February 12, 2018, announcing the total number of shares and voting rights as of January 31, 2018. This information is mandated by French commercial code and AMF regulations (Article L.233-8 II du Code de Commerce et de l'article 223-16 du Règlement Général de l'AMF). The core content is a mandatory disclosure regarding the capital structure and voting power, which directly relates to significant share ownership changes or capital structure reporting, but specifically focuses on the total count of shares/votes, which is often reported alongside major shareholding notifications or capital structure updates. Given the options, this type of mandatory disclosure about the total number of shares and voting rights aligns most closely with either 'Major Shareholding Notification' (MRQ) or 'Share Issue/Capital Change' (SHA). Since it is a periodic update of the total share count rather than a notification of a specific threshold crossing or a new issuance/repurchase event, it is a fundamental capital structure disclosure. However, the closest fit among the provided codes for mandatory regulatory disclosures about share counts and voting rights, especially when not tied to a specific transaction (like POS or SHA), is often grouped with major shareholding changes or general regulatory filings. Since it explicitly details the 'Nombre d'actions composant le capital' and 'Nombre de droits de vote', it is a direct report on the capital base. 'SHA' (Share Issue/Capital Change) covers capital structure changes. 'MRQ' covers changes in significant share ownership. Because this is a formal, periodic disclosure of the total capital base required by regulators, and it is not a general announcement of a report (RPA), it is best classified as a report detailing the capital structure. In many contexts, this specific type of filing is categorized under capital structure updates. I will select SHA as it directly concerns the composition of the capital base, although MRQ is also plausible if the context implies this is filed when thresholds are crossed. Given the explicit table detailing the total share count, SHA is the most appropriate fit for a capital structure report.
2018-02-12 French
Information relating to the total number of voting rights and shares making up the capital
Share Issue/Capital Change Classification · 1% confidence The document is titled "Number of shares and voting rights of ADOCIA as of January 31, 2018" and explicitly references compliance with Article L. 233-8 II of the French « Code de Commerce » and Article 223-16 of the AMF charter. It provides a table detailing the total number of outstanding shares and the total number of theoretical and exercisable voting rights as of a specific date (January 31, 2018). This type of mandatory disclosure regarding the total share capital and voting power is typically classified as a regulatory filing or a specific announcement related to share capital structure. Since the document is a direct announcement of share/voting rights figures, it most closely aligns with a general regulatory filing (RNS) or potentially a specific capital/share change announcement. However, given the context of mandatory disclosure of share capital figures, it is a specific type of regulatory update. It is not a Director's Dealing (DIRS), a Major Shareholding Notification (MRQ, which concerns changes by *other* entities crossing thresholds), or a Share Issue/Capital Change (SHA, which usually announces the *action* of issuing/changing capital). The most appropriate general category for mandatory, periodic disclosure of share capital structure figures, especially when referencing specific regulatory articles, is Regulatory Filings (RNS), as it is a specific regulatory disclosure that doesn't fit the other precise categories like DIV or DIRS. Given the content is a direct report of voting rights figures, it is a specific regulatory disclosure.
2018-02-12 English
Communicated under the obligation to provide permanent information / Other communications
Report Publication Announcement Classification · 1% confidence The document is explicitly titled "PRESS RELEASE" and announces that the CEO will present at an external industry event, the "2018 BIO CEO & Investor Conference." It details the date, time, and location of the presentation and mentions management availability for one-on-one meetings. This type of announcement, focusing on management's schedule for investor engagement at a conference, is best classified as an Investor Presentation (IP) announcement or, more broadly, a communication aimed at investors regarding future engagement opportunities. However, since the document itself is a press release announcing participation in an investor conference where presentations will be given, it strongly aligns with the intent of an Investor Presentation (IP) or a general announcement. Given the options, it is not a formal regulatory filing (like 10-K or IR), nor is it a dividend notice or earnings release. It is an announcement about management's upcoming investor outreach. If the document were the actual presentation slides, it would be IP. As a press release *about* presenting, it fits best under Investor Presentation (IP) as it is directly related to investor relations activities, or potentially RNS if it were purely administrative. Since the content is about the company's pipeline and strategy being presented to investors, IP is the most specific fit among the choices for this type of proactive investor communication, although RPA or RNS could also be argued if it were just a notice of a future event. Given the substance provided (pipeline details), IP is chosen over the generic RPA/RNS.
2018-02-09 English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Investor Presentation Classification · 1% confidence The document is titled "COMMUNIQUE DE PRESSE" (Press Release) and announces that the CEO of Adocia will be giving a presentation at the BIO CEO & Investor conference in New York, including the date, time, and location. It also mentions that management will meet with investors (1x1 meetings). This content is characteristic of an announcement intended to inform investors about management's upcoming participation in an investor-focused event, which aligns best with an Investor Presentation (IP) announcement or a general communication about investor relations activities. Since the document itself is the announcement of management presenting company strategy and portfolio to investors at a conference, it strongly suggests the context of an Investor Presentation (IP). It is not the presentation slides themselves, but the announcement of management's participation in an event where they will present. Given the options, 'Investor Presentation' (IP) is the most fitting category for an announcement detailing management's scheduled presentation and investor meetings at a specific conference.
2018-02-09 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.